i-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations.
Jiang J, Chen Y, Zhang L, Jin Q, Wang L, Xu S, Chen K, Li L, Zeng T, Fan X, Liu T, Li J, Wang J, Han C, Gao F, Yang Y, Wang Y.
Jiang J, et al. Among authors: han c.
Mol Cancer. 2022 Aug 16;21(1):164. doi: 10.1186/s12943-022-01612-x.
Mol Cancer. 2022.
PMID: 35974394
Free PMC article.